melanin
176 Results
Erweiterte Suche
Suchergebnisse
Suche eingrenzen Grenzen Sie Ihre Suche mit den nachstehenden Filtern ein
Produkte nach Art
Markenname
Hauptanwendungen
Antikörperart
Format
Speziesreaktivität
Neue Produkte
Gensymbol
Forschungskategorie
Forschungsunterkategorie
Vergleichen
Wählen Sie das Kontrollkästchen von bis zu 4 Produkten und klicken Sie dann auf „Vergleichen“, um einen detaillierten Produktvergleich zu erhalten.
AB5861 Sigma-AldrichAnti-Melanin Concentrating Hormone Receptor Type 2 Antibody, intracellular, CT
This Anti-Melanin Concentrating Hormone Receptor Type 2 Antibody, intracellular, C-terminus is validated for use in IH for the detection of Melanin Concentrating Hormone Receptor Type 2.
HTS025RTA Sigma-AldrichReady-to-Assay™ MCH1 Melanin-Concentrating Hormone Receptor Frozen Cells
Human MCHR1 / GPR24 GPCR frozen cells for Calcium Flux FLIPR Assays.
HTS026RTA Sigma-AldrichReady-to-Assay™ MCH2 Melanin-Concentrating Hormone Receptor Frozen Cells
Human MCHR2 GPCR frozen cells for Calcium Flux FLIPR Assays.
MABN770 Sigma-AldrichAnti-Melanopsin Antibody, clone 1F8.1
This Anti-Melanopsin Antibody, clone 1F8.1 is validated for use in Western Blotting, Immunohistochemistry (Paraffin) for the detection of Melanopsin .
HTS155RTA Sigma-AldrichReady-to-Assay™ MC5 Melanocortin Receptor Frozen Cells
Human MC5 GPCR frozen cells for Calcium Flux FLIPR Assays.
HTS021RTA Sigma-AldrichReady-to-Assay™ MC2 Melanocortin Receptor Frozen Cells
Human MC2 GPCR frozen cells for Calcium Flux FLIPR Assays.
HTS156M Sigma-AldrichChemiSCREEN™ Membrane Preparation Recombinant Human MC1 Melanocortin Receptor
Human MC1 GPCR membrane preparation for Radioligand binding Assays & GTPγS binding.
HTS155M Sigma-AldrichChemiSCREEN™ Membrane Preparation Recombinant Human MC5 Melanocortin Receptor
Human MC5 GPCR membrane preparation for Radioligand binding Assays & GTPγS binding.
SCC439 Sigma-AldrichSK-MEL-103 Human Melanoma Cell Line
SK-MEL-103 is a human metastatic melanoma cell line that retains a Q61R NRAS mutation which is associated with a more aggressive phenotype, higher metastasis risk, and therefore a poorer prognosis.